Population pharmacokinetics of favipiravir in patients with COVID‐19

Population pharmacokinetics of favipiravir in patients with COVID‐19

Abstract The antiretroviral drug favipiravir (FPV) inhibits RNA‐dependent RNA polymerase. It has been developed for the treatment of the novel coronavirus (severe acute respiratory syndrome coronavirus 2) infection disease, coronavirus disease 2019 (COVID‐19). However, its pharmacokinetics in patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Kei Irie (Author), Atsushi Nakagawa (Author), Hirotoshi Fujita (Author), Ryo Tamura (Author), Masaaki Eto (Author), Hiroaki Ikesue (Author), Nobuyuki Muroi (Author), Shoji Fukushima (Author), Keisuke Tomii (Author), Tohru Hashida (Author)
Format: Book
Published: Wiley, 2021-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items